Markets:

Overview

News

Currencies

International

Treasuries

Gossamer Bio, Inc. - Common Stock (NQ:GOSS)

2.435 -0.085 (-3.37%)

Streaming Delayed Price Updated: 10:17 AM EST, Jan 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gossamer Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Gossamer Bio Announces Seralutinib Meets Primary Endpoint in Phase 2 TORREY Study in PAH

December 06, 2022

From Gossamer Bio, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

November 30, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

November 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Analyst Expects 'Somewhat Smaller Effect Size' From Gossamer Bio's Upcoming PAH Trial ↗

November 17, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Gossamer Bio ↗

November 17, 2022

Via Benzinga

Analyst Ratings for Gossamer Bio ↗

November 17, 2022

Via Benzinga

4 Analysts Have This to Say About Gossamer Bio ↗

November 17, 2022

Via Benzinga

What 5 Analyst Ratings Have To Say About Gossamer Bio ↗

October 20, 2022

Analysts have provided the following ratings for Gossamer Bio (NASDAQ:GOSS) within the last quarter:

Via Benzinga

Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update

November 03, 2022

From Gossamer Bio, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022 ↗

October 20, 2022

Upgrades

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 ↗

September 21, 2022

Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago...

Via Benzinga

What 4 Analyst Ratings Have To Say About Gossamer Bio ↗

September 19, 2022

Within the last quarter, Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings:

Via Benzinga

Where Gossamer Bio Stands With Analysts ↗

September 19, 2022

Within the last quarter, Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2022 ↗

September 19, 2022

Upgrades

Via Benzinga

Analyst Ratings for Gossamer Bio ↗

September 19, 2022

Gossamer Bio (NASDAQ:GOSS) has observed the following analyst ratings within the last quarter:

Via Benzinga

Gossamer Bio: Q2 Earnings Insights ↗

August 09, 2022

Gossamer Bio (NASDAQ:GOSS) reported its Q2 earnings results on Tuesday, August 9, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update

August 09, 2022

From Gossamer Bio, Inc.

Via Business Wire

Beyond Meat, Canoo, Veru And More: 12 Short Squeeze Candidates To Watch ↗

July 20, 2022

One of the most powerful tradable market events is a short squeeze, so traders are always on the lookout for the next short squeeze candidate. S3 Partners analyst Ihor Dusaniwsky has just released a...

Via Benzinga

Insider Buying This Major Airline Stock, Here's 3 Stocks Insiders Are Buying ↗

July 18, 2022

Although US stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

July 14, 2022

Via Benzinga

Why Cannabis Companies Traded Higher; Here's 60 Biggest Movers From Yesterday ↗

July 15, 2022

Gainers

Via Benzinga

Dow Sinks Amid Disappointing Data, Bank Earnings ↗

July 14, 2022

Wall Street worries over potential rate hikes from the Fed following yesterday's inflation reading.

Via Talk Markets

Analyst Ratings for Gossamer Bio ↗

July 14, 2022

Over the past 3 months, 5 analysts have published their opinion on Gossamer Bio (NASDAQ:GOSS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday ↗

July 14, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 13, 2022

Via Benzinga

Twitter, Delta Air Lines And 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 13, 2022

Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 122.4% to $6.76. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th.

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program ↗

July 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 13, 2022

Via Benzinga

Gossamer Bio Announces $120 Million Private Placement Financing

July 13, 2022

From Gossamer Bio, Inc.

Via Business Wire

Gossamer Bio Announces Publication of Key Preclinical Data in the European Respiratory Journal Highlighting Seralutinib’s Potential for the Treatment of PAH

June 09, 2022

From Gossamer Bio, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.